← Back to news
S

Seeking Alpha: News

Universal outlines push to return uncommitted tobacco inventory to 20% target while navigating oversupply

B

Oil prices jump as Iran weighs ban of U.S. ships from Hormuz; Houthis attack Saudi forces in Yemen

B

Macom outlines Q4 FY 2026 revenue of $415M-$425M with adjusted EPS of $1.97-$2.03 as backlog hits record 1.6:1 book-to-bill

B

Alarm.com raises 2026 outlook to $754.4M SaaS revenue while targeting 21% adjusted EBITDA margin exiting 2027

B

Natera outlines $2.85B-$2.91B 2026 revenue outlook backed by 31% growth ex true-ups

B

Viatris raises 2026 outlook while targeting $500M peak sales for fast-acting meloxicam

B

WillScot signals 2026 revenue of ~$2.3B and net CapEx of ~$375M as large-project demand drives outlook raise

S

Halozyme projects 2026 non-GAAP EPS of $8.65-$9.00 while raising revenue outlook to $1.835B-$1.91B

S

Sunstone expects 2026 RevPAR growth of 7%-9% following Hyatt Regency San Francisco sale

S

ConocoPhillips targets $7B free cash flow inflection by 2029 as it outlines CEO transition and keeps full-year guidance unchanged

S

Tripadvisor expects Q3 experiences booked growth of 5% to 7% amid TheFork sale process

S

Arrow Electronics outlines Q3 sales of $9.6B-$10.2B with non-GAAP EPS of $4.83-$5.03

S

Pennant anticipates $1.17B-$1.19B 2026 revenue as it raises EPS outlook to $1.34-$1.41

S

AMSC expects Q2 fiscal 2026 revenue to exceed $85M while scaling Brazil capacity

S

Turtle Beach reaffirms 2026 revenue $335M-$355M outlook as it targets mid- to high 30% gross margin

B

Trump signs order setting 15% tariff, price floors on polysilicon imports

B

GoodRx projects $790M-$805M revenue and $240M-$250M adjusted EBITDA as Pharma Direct targets 70%+ growth

B

Western Midstream outlines 2026 adjusted EBITDA of $2.75B-$2.95B while integrating Brazos acquisition

B

CarParts.com targets free cash flow positive in 2026 with A-Premium near $50M run rate and 300,000-package last-mile goal

B

HCI outlines over $10M per quarter reinsurance savings as GEICO begins selling new product

S

Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year

S

StoneX expects RJO cost synergies to reach a $50M run rate by end of Q1 FY 2027 as volatility moderates

S

FrontView raises 2026 AFFO per share outlook to $1.32-$1.34 as it targets $120M of net investment

S

Atlassian outlines 18% FY 2027 subscription ARR growth with 4.5% GAAP operating margin target

S

Mativ expects $20M-$25M Q3 sales impact from Wisconsin tornado while targeting 2.5x-3.5x net leverage by mid-2027

S

Nephros details integrated water safety platform while expanding in Greater New York and Puerto Rico

S

Establishment Labs signals $269M-$271M 2026 revenue as minimally invasive approaches 15% of sales

S

Novavax expects $235M-$275M in 2026 adjusted total revenue while targeting $150M-$200M in 2028 non-GAAP R&D and SG&A

S

Mueller Water Products targets FY2026 adjusted EBITDA of $367M-$372M while narrowing net sales growth to 2.8%-3.5%

S

Ormat expects $1.15B-$1.2B 2026 revenue while targeting 2.6-2.8 GW by 2028

S

Occidental expects flat production and capex in 2027

S

Koppers outlines 2026 adjusted EBITDA of $240M-$250M as Stickney distillation end moves to Sep. 30, 2026

S

Cooper-Standard targets over $400M of 2026 net new awards while keeping adjusted EBITDA midpoint unchanged

S

Ziff Davis Non-GAAP EPS of $1.03 beats by $0.19, revenue of $286.7M beats by $0.79M

S

Here are the major earnings before the open Friday

S

Valhi GAAP EPS of $0.78, revenue of $606.1M

S

CVRx GAAP EPS of -$0.53 misses by $0.01, revenue of $15.71M beats by $0.16M

S

WELL Health Technologies Non-GAAP EPS of $0.04 misses by $0.02, revenue of $400.43M beats by $13.8M

S

E.W. Scripps reports Q2 results

S

Strawberry Fields REIT FFO of $0.36 misses by $0.02

B

Replimune gains accelerated approval of Tudriqev for cutaneous melanoma

B

Seneca Foods GAAP EPS of $2.85, revenue of $405.17M

B

Geospace Technologies GAAP EPS of -$0.75, revenue of $15.8M

B

B2Gold Non-GAAP EPS of $0.03 misses by $0.04, revenue of $789.35M beats by $65.09M

B

Ambac Financial Group Non-GAAP EPS of -$0.04 misses by $0.03, revenue of $58M misses by $26.28M

B

Rocket Companies shares slid despite record Q2 earnings; figures trail estimates

S

Janux Therapeutics GAAP EPS of -$0.35 misses by $0.09, revenue of $10.27M misses by $7.67M

S

Clipper Realty AFFO of $0.09 beats by $0.06, revenue of $38.6M misses by $0.4M

S

Tectonic Therapeutic Non-GAAP EPS of -$1.18

S